Current Gerontology and Geriatrics Research
Volume 2009 (2009), Article ID 158425, 7 pages
doi:10.1155/2009/158425
Clinical Study

Ten-Year Survival in 75-Year-Old Men and Women: Predictive Ability of Total Cholesterol, HDL-C, and LDL-C

Göran Nilsson,1 John Öhrvik,2 Ingemar Lönnberg,3 and Pär Hedberg1,4

1Centre of Clinical Research, Västerås Central Hospital, Uppsala University, SF-751 05 Uppsala, Sweden
2Department of Medicine, Cardiology Research Unit, Karolinska Institute, SE-17176, Stockholm, Sweden
3Department of Cardiology, Central Hospital, SE-72189 Västerås, Sweden
4Department of Clinical Physiology, Central Hospital, SE-72189 Västerås, Sweden

Received 3 November 2008; Accepted 3 February 2009

Academic Editor: Thomas M. Stulnig

Copyright © 2009 Göran Nilsson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Stamler, D. Wentworth, and J. D. Neaton, “Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT),” The Journal of the American Medical Association, vol. 256, no. 20, pp. 2823–2828, 1986. View at Publisher · View at Google Scholar
  2. J. Stamler, M. L. Daviglus, D. B. Garside, A. R. Dyer, P. Greenland, and J. D. Neaton, “Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity,” The Journal of the American Medical Association, vol. 284, no. 3, pp. 311–318, 2000. View at Publisher · View at Google Scholar
  3. G. De Backer, E. Ambrosioni, K. Borch-Johnsen, et al., “European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts),” European Journal of Cardiovascular Prevention & Rehabilitation, vol. 10, pp. S1–S78, 2003. View at Publisher · View at Google Scholar
  4. S. Lewington, G. Whitlock, R. Clarke, et al., “Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths,” The Lancet, vol. 370, no. 9602, pp. 1829–1839, 2007. View at Publisher · View at Google Scholar · View at PubMed
  5. T. Gordon, W. P. Castelli, M. C. Hjortland, W. B. Kannel, and T. R. Dawber, “High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study,” The American Journal of Medicine, vol. 62, no. 5, pp. 707–714, 1977. View at Publisher · View at Google Scholar
  6. P. Barter, A. M. Gotto, J. C. LaRosa, et al., “HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events,” The New England Journal of Medicine, vol. 357, no. 13, pp. 1301–1310, 2007. View at Publisher · View at Google Scholar · View at PubMed
  7. R. Clarke, J. R. Emberson, S. Parish, et al., “Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men,” Archives of Internal Medicine, vol. 167, no. 13, pp. 1373–1378, 2007. View at Publisher · View at Google Scholar · View at PubMed
  8. R. D. Abbott, P. W. Wilson, W. B. Kannel, and W. P. Castelli, “High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham study,” Arteriosclerosis, vol. 8, no. 3, pp. 207–211, 1988.
  9. P. Zimetbaum, W. H. Frishman, W. L. Ooi, et al., “Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study,” Arteriosclerosis and Thrombosis, vol. 12, no. 4, pp. 416–423, 1992.
  10. G. Florvall, S. Basu, and A. Larsson, “Apolipoprotein A1 is a stronger prognostic marker than are HDL and LDL cholesterol for cardiovascular disease and mortality in elderly men,” The Journals of Gerontology Series A, vol. 61, no. 12, pp. 1262–1266, 2006.
  11. Y. Arai and N. Hirose, “Aging and HDL metabolism in elderly people more than 100 years old,” Journal of Atherosclerosis and Thrombosis, vol. 11, no. 5, pp. 246–252, 2004.
  12. P. Hedberg, I. Lönnberg, T. Jonason, G. Nilsson, K. Pehrsson, and I. Ringqvist, “Left ventricular systolic dysfunction in 75-year-old men and women. A population-based study,” European Heart Journal, vol. 22, no. 8, pp. 676–683, 2001. View at Publisher · View at Google Scholar · View at PubMed
  13. NCEP, Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adult treatment panel III), NIH Publication no. 01-3670, National Cholesterol Education Program, Bethesda, Md, USA, 2001.
  14. S. M. Grundy, G. J. Balady, M. H. Criqui, et al., “Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association,” Circulation, vol. 97, no. 18, pp. 1876–1887, 1998.
  15. A. R. Sharrett, C. M. Ballantyne, S. A. Coady, et al., “Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study,” Circulation, vol. 104, no. 10, pp. 1108–1113, 2001. View at Publisher · View at Google Scholar
  16. E. Ingelsson, E. J. Schaefer, J. H. Contois, et al., “Clinical utility of different lipid measures for prediction of coronary heart disease in men and women,” The Journal of the American Medical Association, vol. 298, no. 7, pp. 776–785, 2007. View at Publisher · View at Google Scholar · View at PubMed
  17. J. Wang, S. Ruotsalainen, L. Moilanen, P. Lepistö, M. Laakso, and J. Kuusisto, “The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns,” European Heart Journal, vol. 28, no. 7, pp. 857–864, 2007. View at Publisher · View at Google Scholar · View at PubMed
  18. I. Shai, E. B. Rimm, S. E. Hankinson, et al., “Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines,” Circulation, vol. 110, no. 18, pp. 2824–2830, 2004. View at Publisher · View at Google Scholar · View at PubMed
  19. P. P. Toth, “High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies,” The American Journal of Cardiology, vol. 96, no. 9, supplement 1, pp. 50–58, 2005. View at Publisher · View at Google Scholar · View at PubMed
  20. T. A. Manolio, M. Cushman, J. S. Gottdiener, A. Dobs, L. H. Kuller, and R. A. Kronmal, “Predictors of falling cholesterol levels in older adults: the Cardiovascular Health Study,” Annals of Epidemiology, vol. 14, no. 5, pp. 325–331, 2004. View at Publisher · View at Google Scholar · View at PubMed
  21. A. W. E. Weverling-Rijnsburger, G. J. Blauw, A. M. Lagaay, D. L. Knook, A. E. Meinders, and R. G. J. Westendorp, “Total cholesterol and risk of mortality in the oldest old,” The Lancet, vol. 350, no. 9085, pp. 1119–1123, 1997. View at Publisher · View at Google Scholar
  22. J. D. Neaton, H. Blackburn, D. Jacobs, et al., “Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial,” Archives of Internal Medicine, vol. 152, no. 7, pp. 1490–1500, 1992. View at Publisher · View at Google Scholar
  23. J. D. Neaton and D. Wentworth, “Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall findings and differences by age for 316 099 white men,” Archives of Internal Medicine, vol. 152, no. 1, pp. 56–64, 1992. View at Publisher · View at Google Scholar
  24. G. D. Smith, M. J. Shipley, M. G. Marmot, and G. Rose, “Plasma cholesterol concentration and mortality: the Whitehall Study,” The Journal of the American Medical Association, vol. 267, no. 1, pp. 70–76, 1992. View at Publisher · View at Google Scholar
  25. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” The Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Publisher · View at Google Scholar
  26. H. M. Krumholz, T. E. Seeman, S. S. Merrill, et al., “Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years,” The Journal of the American Medical Association, vol. 272, no. 17, pp. 1335–1340, 1994. View at Publisher · View at Google Scholar
  27. E. A. Anum and T. Adera, “Hypercholesterolemia and coronary heart disease in the elderly: a meta-analysis,” Annals of Epidemiology, vol. 14, no. 9, pp. 705–721, 2004. View at Publisher · View at Google Scholar · View at PubMed
  28. R. Benfante and D. Reed, “Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly?,” The Journal of the American Medical Association, vol. 263, no. 3, pp. 393–396, 1990. View at Publisher · View at Google Scholar
  29. I. J. Schatz, K. Masaki, K. Yano, R. Chen, B. L. Rodriguez, and J. D. Curb, “Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study,” The Lancet, vol. 358, no. 9279, pp. 351–355, 2001. View at Publisher · View at Google Scholar · View at PubMed
  30. R. A. Kronmal, K. C. Cain, Z. Ye, and G. S. Omenn, “Total serum cholesterol levels and mortality risk as a function of age: a report based on the Framingham data,” Archives of Internal Medicine, vol. 153, no. 9, pp. 1065–1073, 1993. View at Publisher · View at Google Scholar
  31. “JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice,” Heart, vol. 91, pp. 1–52, 2005. View at Publisher · View at Google Scholar · View at PubMed
  32. “Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S),” The Lancet, vol. 344, no. 8934, pp. 1383–1389, 1994.
  33. R. P. Byington, J. W. Jukema, J. T. Salonen, et al., “Reduction in cardiovascular events during pravastatin therapy: pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program,” Circulation, vol. 92, no. 9, pp. 2419–2425, 1995.
  34. J. C. LaRosa, J. He, and S. Vupputuri, “Effect of statins on risk of coronary disease. A meta-analysis of randomized controlled trials,” The Journal of the American Medical Association, vol. 282, no. 24, pp. 2340–2346, 1999. View at Publisher · View at Google Scholar
  35. C. Baigent, A. Keech, P. M. Kearney, et al., “Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins,” The Lancet, vol. 366, no. 9493, pp. 1267–1278, 2005. View at Publisher · View at Google Scholar · View at PubMed
  36. Heart Protection Study Collaborative Group, “MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial,” The Lancet, vol. 360, no. 9326, pp. 7–22, 2002. View at Publisher · View at Google Scholar · View at PubMed
  37. J. R. Downs, M. Clearfield, S. Weis, et al., “Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study,” The Journal of the American Medical Association, vol. 279, no. 20, pp. 1615–1622, 1998. View at Publisher · View at Google Scholar